Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Chembio Diagnostics stock

Learn how to easily invest in Chembio Diagnostics stock.

Chembio Diagnostics Inc is a diagnostics & research business based in the US. Chembio Diagnostics shares (CEMI) are listed on the NASDAQ and all prices are listed in US Dollars. Chembio Diagnostics employs 355 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Chembio Diagnostics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CEMI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Chembio Diagnostics stock price (NASDAQ: CEMI)

Use our graph to track the performance of CEMI stocks over time.

Chembio Diagnostics shares at a glance

Information last updated 2022-01-24.
Latest market close$0.91
52-week range$0.84 - $8.75
50-day moving average $1.59
200-day moving average $2.60
Wall St. target price$8.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.24

Buy Chembio Diagnostics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
M1 Finance
Free 1-year trial of M1 Plus
when you sign up for M1 Finance
Invest in your favorite stocks or in curated portfolios with automatic rebalancing.
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$1 per month
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Stocks, ETFs, Cryptocurrency
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Chembio Diagnostics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Chembio Diagnostics price performance over time

Historical closes compared with the close of $0.9061 from 2022-01-24

1 week (2022-01-18) -12.03%
1 month (2021-12-23) -47.93%
3 months (2021-10-25) -60.94%
6 months (2021-07-23) -70.39%
1 year (2021-01-25) -86.17%
2 years (2020-01-24) -78.43%
3 years (2019-01-25) 6.84
5 years (2017-01-25) 5.95

Chembio Diagnostics financials

Revenue TTM $37.5 million
Gross profit TTM $-912,784
Return on assets TTM -17.79%
Return on equity TTM -66.14%
Profit margin -72.24%
Book value $1.60
Market capitalisation $26.2 million

TTM: trailing 12 months

Chembio Diagnostics share dividends

We're not expecting Chembio Diagnostics to pay a dividend over the next 12 months.

Have Chembio Diagnostics's shares ever split?

Chembio Diagnostics's shares were split on a 1:8 basis on 29 May 2012. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Chembio Diagnostics shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for Chembio Diagnostics shares which in turn could have impacted Chembio Diagnostics's share price.

Chembio Diagnostics share price volatility

Over the last 12 months, Chembio Diagnostics's shares have ranged in value from as little as $0.8401 up to $8.75. A popular way to gauge a stock's volatility is its "beta".

CEMI.US volatility(beta: 1.68)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Chembio Diagnostics's is 1.6756. This would suggest that Chembio Diagnostics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Chembio Diagnostics overview

Chembio Diagnostics, Inc. , together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, Hepatitis C, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, Rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as under the private labels of its marketing partners to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.

Frequently asked questions

What percentage of Chembio Diagnostics is owned by insiders or institutions?
Currently 5.655% of Chembio Diagnostics shares are held by insiders and 12.98% by institutions.
How many people work for Chembio Diagnostics?
Latest data suggests 355 work at Chembio Diagnostics.
When does the fiscal year end for Chembio Diagnostics?
Chembio Diagnostics's fiscal year ends in December.
Where is Chembio Diagnostics based?
Chembio Diagnostics's address is: 555 Wireless Boulevard, Hauppauge, NY, United States, 11788
What is Chembio Diagnostics's ISIN number?
Chembio Diagnostics's international securities identification number is: US1635722093
What is Chembio Diagnostics's CUSIP number?
Chembio Diagnostics's Committee on Uniform Securities Identification Procedures number is: 163572100

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site